Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Information Processing at Sleep Onset and During Sleep in Patients With Insomnia (COTE)

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00680199
First received: May 15, 2008
Last updated: October 18, 2010
Last verified: October 2010

May 15, 2008
October 18, 2010
June 2008
July 2010   (final data collection date for primary outcome measure)
The intent of this study is to assess whether patients with insomnia exhibit an increased level of information processing (as assessed with ERP methods) at sleep onset and during polysomnographically defined sleep. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00680199 on ClinicalTrials.gov Archive Site
Assess spindle and K-complex density to investigate whether the groups differ with respect to these putative markers of information processing and parse ERP trials in NREM into those with and without spindles and K-complexes in order to investigate their [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Information Processing at Sleep Onset and During Sleep in Patients With Insomnia
Information Processing at Sleep Onset and During Sleep in Patients With Insomnia

Chronic insomnia is thought to occur as a result of hyperarousal. While there is a wealth of data to support this position, there is a lack of research to define how hyperarousal interferes with sleep initiation, maintenance, and the perception of sleep quality and quantity. We propose to use Event-related Potential (ERP) techniques to evaluate information processing at sleep onset and during sleep. ERP measures of information processing have been well established in good sleepers; they have not been, however, applied to the problem of insomnia. The goal of the project is to examine the premise that the occurrence and severity of insomnia is fundamentally related to a neurobiologic preparedness to "attend to" and "identify" environmental stimuli. Following an extensive screening, patients with insomnia and good sleepers will participate in two experimental conditions, requiring that they spend four nights in the sleep laboratory over a two week period. ERP data will be gathered prior to, following, and during sleep.

The ultimate objectives for this line of research are to determine 1) if insomnia is associated with a failure to inhibit information processing at sleep onset and/or during sleep, 2) if the failure to inhibit information processing at sleep onset and/or during sleep is associated with the occurrence and/or severity of insomnia symptoms, 3) what brain regions are functioning differently so as to give rise to information processing abnormalities, and 4) the extent to which pharmacologic and/or Cognitive Behavioral treatment for insomnia alters information processing abnormalities and/or the associated brain activity.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Community Sample

Primary Insomnia
Not Provided
  • 1
    Primary Insomnia
  • 2
    Good Sleepers
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
July 2010
July 2010   (final data collection date for primary outcome measure)

Inclusion Criteria for Psychophysiologic Insomnia (PI)

These subjects will meet RDC criteria for Psychophysiologic insomnia. In addition, the complaint of disturbed sleep will have at least one of the following minimal characteristics:

  • > 30 min. sleep-onset latency (SL) (Initial Insomnia)
  • >2 awakenings per night (>15 min. ea.) and/or wake after sleep-onset (WASO) of > 30 min (Middle Insomnia)

Total Sleep Time (TST) will not exceed 6 hours [unless the Sleep Efficiency (SE) quotient is < 80%] and the problem frequency must be > 4 nights/week (Severe Insomnia) with a problem duration > 6 months (Chronic Insomnia)B .

Inclusion Criteria for Good Sleeper Subjects

  • Report that they obtain enough sleep and that their sleep is restorative
  • Have a score of less than 10 on the Epworth Sleepiness Scale (ESS)50-52
  • Have a score of less than 15 on the Ford Insomnia Response to Stress Test (FIRST)53
  • Have a score of less than 7 on the Insomnia Severity Index (ISI)54
  • Report retrospectively and prospectively < 15 minutes to fall asleep and "wake after sleep onset time" of < 15 minutes and a total sleep time > 6 hoursA

A These profiles will be evident at both intake (based on retrospective reports) and as an average from the two weeks of baseline diaries (based on prospective sampling).

Exclusion Criteria for All Subjects

• Unstable medical illness or acute or history of psychiatric illness (except GAD or MDD - Allowed provided that these have resolved and not recurred within 5 years) As ascertained with self report questionnaires, a clinical History, a physical exam and a clinical chemistry profile.

To assure that the insomnia is not secondary to these factors

  • Symptoms suggestive of sleep disorders other than insomnia To assure that the insomnia is not secondary to these factors
  • Polysomnographic data indicating sleep disorders other than insomnia To assure that the insomnia is not secondary to these factors
  • History of head injury with a sustained loss of consciousness To help assure that the EEG measures are unconfounded by brain damage
  • Evidence of active illicit substance use or fitting criteria for alcohol abuse or dependence To assure that the insomnia is not secondary to these factors
  • Use of CNS active medications including antidepressants and hypnotics (within 2 weeks or 5 half-lives) To help assure that the EEG measures are unconfounded by medication effects such as the "BZ artifact".
  • Inadequate language comprehension To assure the quality of self report data as all the measures are in English.
  • Pregnancy Excluded owing to the hormonal changes that occur with pregnancy
  • Left Handedness To control for EEG differences related to handedness
  • Nicotine Use To assure that the insomnia is not secondary to these factors
  • Caffeine use that exceeds 2 beverages per day or occurs past 5pm in the evening.

To assure that the insomnia is not secondary to these factors

Both
25 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00680199
RSRB # 20615, R21MH076855
No
Sara Matteson-Rusby, Psy.D../Primary Investigator, University of Rochester
University of Rochester
National Institutes of Health (NIH)
Principal Investigator: Sara E Matteson-Rusby, Psy.D. University of Rochester
University of Rochester
October 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP